If you need more lookups,
subscriptions start at $34 USD/month.
Shawn Singh Location
South San Francisco, CA, US
Shawn Singh Work
President, Chief Executive Officer and Director @ (August 2009 - Present)
Managing Principal @ Cato BioVentures (February 2001 - August 2009)
Chief Business Officer and General Counsel @ Cato Research (now Allucent) (February 2001 - August 2009)
President and Director @ (September 2007 - June 2009)
Managing Director @ Start-up Law (November 2000 - February 2001)
Chief Business Officer @ (November 1993 - November 2000)
Associate, Business and Corporte Finance Group @ (May 1991 - November 1993)
Shawn Singh Education
University of Maryland Francis King Carey School of Law
Juris Doctor (Law)
1988-1991
University of California, Berkeley
BA with Honors (Political Science)
1982-1985
Shawn Singh Skills
Biotechnology
Clinical Development
Clinical Trials
Drug Development
Clinical Research
Assay Development
Toxicology
Neurology
Medicinal Chemistry
Pharmaceutics
Lifesciences
Licensing
Mergers & Acquisitions
Corporate Governance
Intellectual Property
Venture Capital
Pain Management
Pharmaceutical Industry
Laboratory
Due Diligence
Medical Devices
Technology Transfer
Life Sciences
Start-ups
Management
Strategy
Leadership
Strategic Planning
CRO
Program Management
CRO Management
Microsoft Excel
Start Ups
Finance
Business Development
Mergers and Acquisitions
Shawn Singh Summary
Shawn Singh, based in South San Francisco, CA, US, is currently a President, Chief Executive Officer and Director at Vistagen. Shawn Singh brings experience from previous roles at Cato BioVentures, Cato Research (now Allucent), Echo Therapeutics and Start-up Law. Shawn Singh holds a 1988 - 1991 Juris Doctor in Law @ University of Maryland Francis King Carey School of Law. With a robust skill set that includes Biotechnology, Clinical Development, Clinical Trials, Drug Development, Clinical Research and more. Shawn Singh has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Shawn Singh?
Find contact details for 700 million professionals.